152 related articles for article (PubMed ID: 12102724)
1. Gramicidin S: a peptide model for protein glycation and reversal of glycation using nucleophilic amines.
Shakkottai VG; Sudha R; Balaram P
J Pept Res; 2002 Aug; 60(2):112-20. PubMed ID: 12102724
[TBL] [Abstract][Full Text] [Related]
2. Helical peptide models for protein glycation: proximity effects in catalysis of the Amadori rearrangement.
Venkatraman J; Aggarwal K; Balaram P
Chem Biol; 2001 Jul; 8(7):611-25. PubMed ID: 11451663
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of advanced protein glycation by a Schiff base between aminoguanidine and pyridoxal.
Taguchi T; Sugiura M; Hamada Y; Miwa I
Eur J Pharmacol; 1999 Aug; 378(3):283-9. PubMed ID: 10493104
[TBL] [Abstract][Full Text] [Related]
4. Proteomic analysis of the site specificity of glycation and carboxymethylation of ribonuclease.
Brock JW; Hinton DJ; Cotham WE; Metz TO; Thorpe SR; Baynes JW; Ames JM
J Proteome Res; 2003; 2(5):506-13. PubMed ID: 14582647
[TBL] [Abstract][Full Text] [Related]
5. Kinetics of nonenzymatic glycation of ribonuclease A leading to advanced glycation end products. Paradoxical inhibition by ribose leads to facile isolation of protein intermediate for rapid post-Amadori studies.
Khalifah RG; Todd P; Booth AA; Yang SX; Mott JD; Hudson BG
Biochemistry; 1996 Apr; 35(15):4645-54. PubMed ID: 8664253
[TBL] [Abstract][Full Text] [Related]
6. In vitro kinetic studies of formation of antigenic advanced glycation end products (AGEs). Novel inhibition of post-Amadori glycation pathways.
Booth AA; Khalifah RG; Todd P; Hudson BG
J Biol Chem; 1997 Feb; 272(9):5430-7. PubMed ID: 9038143
[TBL] [Abstract][Full Text] [Related]
7. Does glycation really distort the peptide α-helicity?
Mariño L; Casasnovas R; Ramis R; Vilanova B; Ortega-Castro J; Frau J; Adrover M
Int J Biol Macromol; 2019 May; 129():254-266. PubMed ID: 30738904
[TBL] [Abstract][Full Text] [Related]
8. Glycation of amino groups in protein. Studies on the specificity of modification of RNase by glucose.
Watkins NG; Thorpe SR; Baynes JW
J Biol Chem; 1985 Sep; 260(19):10629-36. PubMed ID: 4030761
[TBL] [Abstract][Full Text] [Related]
9. Amadorins: novel post-Amadori inhibitors of advanced glycation reactions.
Khalifah RG; Baynes JW; Hudson BG
Biochem Biophys Res Commun; 1999 Apr; 257(2):251-8. PubMed ID: 10198198
[TBL] [Abstract][Full Text] [Related]
10. Diagnostic MS/MS fragmentation patterns for the discrimination between Schiff bases and their Amadori or Heyns rearrangement products.
Xing H; Mossine VV; Yaylayan V
Carbohydr Res; 2020 May; 491():107985. PubMed ID: 32213351
[TBL] [Abstract][Full Text] [Related]
11. ADP-ribose in glycation and glycoxidation reactions.
Jacobson EL; Cervantes-Laurean D; Jacobson MK
Adv Exp Med Biol; 1997; 419():371-9. PubMed ID: 9193679
[TBL] [Abstract][Full Text] [Related]
12. Amadori product and age formation during nonenzymatic glycosylation of bovine serum albumin in vitro.
Sharma SD; Pandey BN; Mishra KP; Sivakami S
J Biochem Mol Biol Biophys; 2002 Aug; 6(4):233-42. PubMed ID: 12186738
[TBL] [Abstract][Full Text] [Related]
13. Identification of AGE-precursors and AGE formation in glycation-induced BSA peptides.
Ahmad W; Li L; Deng Y
BMB Rep; 2008 Jul; 41(7):516-22. PubMed ID: 18682035
[TBL] [Abstract][Full Text] [Related]
14. The role of oxidative stress in the long-term glycation of LDL.
Menzel EJ; Sobal G; Staudinger A
Biofactors; 1997; 6(2):111-24. PubMed ID: 9259992
[TBL] [Abstract][Full Text] [Related]
15. Relative quantification of N(epsilon)-(Carboxymethyl)lysine, imidazolone A, and the Amadori product in glycated lysozyme by MALDI-TOF mass spectrometry.
Kislinger T; Humeny A; Peich CC; Zhang X; Niwa T; Pischetsrieder M; Becker CM
J Agric Food Chem; 2003 Jan; 51(1):51-7. PubMed ID: 12502384
[TBL] [Abstract][Full Text] [Related]
16. Unexpected crosslinking and diglycation as advanced glycation end-products from glyoxal.
Lopez-Clavijo AF; Duque-Daza CA; Soulby A; Canelon IR; Barrow M; O'Connor PB
J Am Soc Mass Spectrom; 2014 Dec; 25(12):2125-33. PubMed ID: 25315462
[TBL] [Abstract][Full Text] [Related]
17. Structure of a synthetic glucose derived advanced glycation end product that is immunologically cross-reactive with its naturally occurring counterparts.
Al-Abed Y; Bucala R
Bioconjug Chem; 2000; 11(1):39-45. PubMed ID: 10639083
[TBL] [Abstract][Full Text] [Related]
18. Identification of a novel advanced glycation end product derived from lactaldehyde.
Fujimoto S; Murakami Y; Miyake H; Hayase F; Watanabe H
Biosci Biotechnol Biochem; 2019 Jun; 83(6):1136-1145. PubMed ID: 30822216
[TBL] [Abstract][Full Text] [Related]
19. The role of advanced glycation end products in various types of neurodegenerative disease: a therapeutic approach.
Salahuddin P; Rabbani G; Khan RH
Cell Mol Biol Lett; 2014 Sep; 19(3):407-37. PubMed ID: 25141979
[TBL] [Abstract][Full Text] [Related]
20. The pyridoxamine action on Amadori compounds: A reexamination of its scavenging capacity and chelating effect.
Adrover M; Vilanova B; Frau J; Muñoz F; Donoso J
Bioorg Med Chem; 2008 May; 16(10):5557-69. PubMed ID: 18434162
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
